Silo Pharma, Inc. (SILO)
Silo Pharma. Inc., a developmental stage biopharmaceutical company, focuses on merging traditional therapeutics with psychedelic research. It is developing solutions to address various underserved conditions. The company seeks to acquire and/or develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs, such as psilocybin, and the benefits they may have in certain cases involving depression, mental health issues, and neurological disorders. The company focuses on merging traditional therapeutics with psychedelic research for people suffering from indications, such as depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey.
$4.66M
2.00
Englewood Cliffs, NJ
Dec 24, 2020
-0.90
$-1.16
0.14
9.09
-6,524.46%
-1.23
0.48
0.70
79.33
8.98
-45.92%
-47.12%
Similar stocks (18)
Day One Biopharmaceuticals, Inc.
DAWN
Terns Pharmaceuticals, Inc.
TERN
UroGen Pharma Ltd.
URGN
Eliem Therapeutics, Inc.
ELYM
Inozyme Pharma, Inc.
INZY
Rezolute, Inc.
RZLT
Shattuck Labs, Inc.
STTK
HOOKIPA Pharma Inc.
HOOK
Acumen Pharmaceuticals, Inc.
ABOS
Century Therapeutics, Inc.
IPSC
Champions Oncology, Inc.
CSBR
Anebulo Pharmaceuticals, Inc.
ANEB
Tempest Therapeutics, Inc.
TPST
Lumos Pharma, Inc.
LUMO
Indaptus Therapeutics, Inc.
INDP
BioCardia, Inc.
BCDA
Forte Biosciences, Inc.
FBRX
Comera Life Sciences Holdings, Inc.
CMRA
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (18)
Day One Biopharmaceuticals, Inc.
DAWN
Terns Pharmaceuticals, Inc.
TERN
UroGen Pharma Ltd.
URGN
Eliem Therapeutics, Inc.
ELYM
Inozyme Pharma, Inc.
INZY
Rezolute, Inc.
RZLT
Shattuck Labs, Inc.
STTK
HOOKIPA Pharma Inc.
HOOK
Acumen Pharmaceuticals, Inc.
ABOS
Century Therapeutics, Inc.
IPSC
Champions Oncology, Inc.
CSBR
Anebulo Pharmaceuticals, Inc.
ANEB
Tempest Therapeutics, Inc.
TPST
Lumos Pharma, Inc.
LUMO
Indaptus Therapeutics, Inc.
INDP
BioCardia, Inc.
BCDA
Forte Biosciences, Inc.
FBRX
Comera Life Sciences Holdings, Inc.
CMRA
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%